Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Parexel Intl Cp (PRXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,463,223
  • Shares Outstanding, K 51,090
  • Annual Sales, $ 2,426 M
  • Annual Income, $ 154,900 K
  • 36-Month Beta 0.79
  • Price/Sales 1.91
  • Price/Cash Flow N/A
  • Price/Book 7.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.80 +0.79%
on 06/23/17
87.86 -0.42%
on 07/17/17
+0.24 (+0.28%)
since 06/21/17
3-Month
62.28 +40.48%
on 04/27/17
87.86 -0.42%
on 07/17/17
+24.65 (+39.23%)
since 04/21/17
52-Week
51.16 +71.01%
on 11/11/16
87.86 -0.42%
on 07/17/17
+22.92 (+35.50%)
since 07/21/16

Most Recent Stories

More News
PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation

PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.

EW : 118.21 (-1.01%)
PRXL : 87.51 (+0.17%)
MLAB : 152.64 (+0.44%)
ALGN : 160.59 (+0.26%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (ILMN, TMO, INCR, PRXL, PKI)

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

PRXL : 87.51 (+0.17%)
ILMN : 172.98 (+0.59%)
INCR : 56.50 (-0.70%)
TMO : 182.16 (+0.34%)
PKI : 69.64 (+0.26%)
PAREXEL Receives CEO Cancer Gold Standard Re-Accreditation

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer...

PRXL : 87.51 (+0.17%)
29.0% Return Seen to Date on SmarTrend Parexel Intl Call (PRXL)

SmarTrend identified an Uptrend for Parexel Intl (NASDAQ:PRXL) on May 4th, 2017 at $67.53. In approximately 2 months, Parexel Intl has returned 29.03% as of today's recent price of $87.13.

PRXL : 87.51 (+0.17%)
Lifshitz&Miller LLP Announces Investigation of ARI Network Services, Inc., DuPont Fabros Technology, Inc., Nexvet Biopharma Public Limited Company, PAREXEL International Corporation, Rice Energy Inc. and SciClone Pharmaceuticals, Inc.

ARI Network Services, Inc. (ARIS)

DFT : 60.63 (+0.18%)
NVET : 6.70 (unch)
PRXL : 87.51 (+0.17%)
SCLN : 10.98 (+0.73%)
ARIS : 7.05 (-0.84%)
RICE : 27.33 (+2.47%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of PAREXEL International Corporation to Pamplona Capital Management, LLP is Fair to Shareholders - PRXL

NEW YORK, NY / ACCESSWIRE / June 27, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

PRXL : 87.51 (+0.17%)
PAREXEL Named to the Forbes America's Best Employers List for Second Consecutive Year

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that for the second year in a row, Forbes has named the Company...

PRXL : 87.51 (+0.17%)
The Law Offices of Vincent Wong Notifies Investors of an Investigation of PAREXEL International Corporation in Connection with the Sale of the Company to Pamplona Capital Management, LLP

The Law Offices of Vincent Wong are investigating the Board of Directors of PAREXEL International Corporation (NASDAQ:PRXL) for possible breaches of fiduciary duty and other violations of...

PRXL : 87.51 (+0.17%)
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of PAREXEL International Corporation - PRXL

BALA CYNWYD, PA / ACCESSWIRE / June 22, 2017 / The law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PAREXEL International Corporation...

PRXL : 87.51 (+0.17%)
Featured Company News - Pamplona to Acquire PAREXEL; Another Contract Researcher Goes Private

Research Desk Line-up: Organovo Post Earnings Coverage

PRXL : 87.51 (+0.17%)
ONVO : 2.38 (+2.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With...

See More

Support & Resistance

2nd Resistance Point 87.62
1st Resistance Point 87.49
Last Price 87.51
1st Support Level 87.28
2nd Support Level 87.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.